Cite
DGG-300273, a novel WNT/β-catenin inhibitor, induces apoptotic cell death by activating ROS-BIM signaling in a Wnt-dependent manner in colon cancer cells.
MLA
Kim, Do Yeon, et al. “DGG-300273, a Novel WNT/β-Catenin Inhibitor, Induces Apoptotic Cell Death by Activating ROS-BIM Signaling in a Wnt-Dependent Manner in Colon Cancer Cells.” Investigational New Drugs, vol. 41, no. 1, Feb. 2023, pp. 105–14. EBSCOhost, https://doi.org/10.1007/s10637-022-01295-7.
APA
Kim, D. Y., Ryu, Y. S., Lee, E.-S., Koh, D.-I., Moon, J.-H., Jung, S.-A., Kim, M. J., Yun, H., You, J.-E., Jeong, H.-R., Yoon, D.-I., Kim, C. H., Hong, S.-W., Gong, Y.-D., & Jin, D.-H. (2023). DGG-300273, a novel WNT/β-catenin inhibitor, induces apoptotic cell death by activating ROS-BIM signaling in a Wnt-dependent manner in colon cancer cells. Investigational New Drugs, 41(1), 105–114. https://doi.org/10.1007/s10637-022-01295-7
Chicago
Kim, Do Yeon, Yea Seong Ryu, Eun-Sil Lee, Dong-In Koh, Jai-Hee Moon, Soo-A Jung, Mi Jin Kim, et al. 2023. “DGG-300273, a Novel WNT/β-Catenin Inhibitor, Induces Apoptotic Cell Death by Activating ROS-BIM Signaling in a Wnt-Dependent Manner in Colon Cancer Cells.” Investigational New Drugs 41 (1): 105–14. doi:10.1007/s10637-022-01295-7.